September is PROSTATE CANCER AWARENESS MONTH.

Posted by admin on August 30th, 2010

Dr. Bert Vorstman is joining other organizations nationwide to promote prostate cancer awareness during September.
Dr Vorstman has developed his website, www.HIFUrx.com as a resource to empower a man and his spouse with knowledge on prostate cancer and treatment options.
Prostate cancer is a silent disease and although most common in men after age 65, some men in their 30′s may also have the disease.
Men with a family history of prostate cancer and men of African American heritage are also at risk.
Prostate cancer is the second leading cause of death in men after lung cancer.
The goal of prostate cancer awareness is to make men and their spouses knowledgeable about the benefits of prostate screening as well as the benefits of early non surgical treatment. Although screening with a DRE and PSA and %free PSA are not perfect,this process will detect a significant number of prostate cancers when they are still localized to the prostate.

Cure and Survival in Localized Prostate Cancer

Posted by admin on August 23rd, 2010

Cure means complete disappearance of disease and restoration of health.
For prostate cancer,many of the data points used to assess the stage of a man’s prostate cancer and his risk for progression of the disease are affected by physician subjectivity for interpreting scale of disorder. If the data points can be so affected by subjectivity then they lack accuracy and therefore the cure rates generated by these data points lack reliability. Because of these concerns for lack of reliability and lack of reproducibility in generating cure rates for prostate cancer,the use of the term survival seems more appropriate as it is less limiting when applied to prostate cancer treatment success.
T1c stage prostate cancer is the most common presentation for prostate cancer currently and is detected because of an abnormal PSA.
This T1c stage defines a localized prostate cancer and the survival benefits between the four different treatment categories for localized prostate cancer are similar. However,of these treatment options for localized prostate cancer,only HIFU is the most precise as well as affording a superior post treatment quality of life (QOL). The continued evolution of this state of the art technology should result in even greater prostate cancer survival benefits in the future.

Recurrent Localized Prostate Cancer Treatment Options

Posted by admin on August 4th, 2010

The same four definitive treatment options available initially for localized prostate cancer are also available for treating a possible recurrence of localized prostate cancer.. These treatment options are High Intensity Focused Ultrasound (HIFU),Cryoablation (freezing),Radiation (various forms) and surgery (various types). The four categories of treatments have similar survival benefits but the first three have less complications than surgery which also has the biggest negative impact on Quality of Life (QOL) issues.
After definitive therapy for for localized prostate cancer your PSA (prostatic specific antigen) should nadir to about 0.1-0.2ng/ml but about 1/3 of treated men will develop a rise in their PSA  at some time.
A rising PSA may not always mean a recurrence of the prostate cancer or an incomplete treatment of the cancer as a temporary “bump” or “bounce” in your PSA after radiation is common.
However,all persistent PSA rises should be evaluated early with a trans-rectal prostate biopsy. After any prostate biopsy you should demand to have your slides sent to a reference laboratory for validation. This is very important as the majority of the prostate biopsies are read by general pathologists and because there is a certain degree of subjectivity involved in determining the presence of prostate cancer,the amount of cancer, as well as the Gleason score,validation is important.
If a man is diagnosed with a recurrence after radiation he is usually offered only active surveillance (AS) or androgen deprivation therapy (ADT) or so called “hormone shots”. Unfortunately,long term ADT has significant downsides with side effects as well as bone wasting and metabolic syndrome events bringing about a negative impact on QOL. HIFU and Cryo are ideal definitive treatment options in men with an early localized prostate cancer recurrence after radiation or in those men where the treatment was incomplete after radiation.
Recurrent prostate cancer after surgical removal is not uncommon either and a man and his spouse are quite mistaken to think that after surgical removal that they can forget about a cancer recurrence because the prostate is gone. Not so. In fact,after surgery (which includes robotics),somewhere between 20-40% of men will have positive margins to their specimens which means that prostate cancer was left behind. Some of these men will be offered AS. Others will be offered radiation,either adjunctive or salvage, to the prostatic bed.
However,if there is a nodule palpable in the prostatic bed and it is proven to be a cancerous recurrence then HIFU may be used to treat this definitively.
The treatment of recurrent cancer in the prostate after radiation or surgery is possible once more using HIFU or Cryo.
Unfortunately,few urologists or radiation oncologists are familiar with or have had the training in the minimally invasive therapies of HIFU or Cryoablation. HIFU is the most precise of these options,as well as being non surgical and non radiation and performed as an outpatient. Furthermore,unlike Cryo or radiation where the treated prostatic cancer tissue remains within the prostatic capsule, after HIFU treatment the treated cancerous tissue is expelled over time during urination. This particular feature of HIFU treatment for prostate cancer may help minimize the chances of a recurrent cancer developing.


Copyright © 2011 HIFU – Latest News. Antivirus scan.